Treatment results and prognostic factors of advanced T3–4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience

« Previous Next »International Journal of Radiation Oncology * Biology * Physics
Volume 50, Issue 5 , Pages 1172-1180, 1 August 2001

Presented at the Annual Meeting of the Radiological Society of North America (RSNA), Chicago, IL, November 26, 2000.

Phuc F Nguyen-Tan, M.D.C.M.
- Department of Radiation Oncology, University of California, San Francisco, CA, USA
- Reprint requests to: Dr. Phuc F. Nguyen-Tan, Department of Radiation Oncology, Hôpital Notre-Dame, 1560 Sherbrooke Street East, Montreal, Quebec, Canada, H2L 4M1
Quynh-Thu Le, M.D.
- Department of Radiation Oncology, Stanford University, Stanford, CA, USA
Jeanne-Marie Quivey, M.D.
- Department of Radiation Oncology, University of California, San Francisco, CA, USA
Mark Singer, M.D.
- Department of Otolaryngology, University of California, San Francisco, CA, USA
David J Terris, M.D.
- Department of Otolaryngology, Stanford University, Stanford, CA, USA
Don R Goffinet, M.D.
- Department of Radiation Oncology, Stanford University, Stanford, CA, USA
Karen K Fu, M.D.
- Department of Radiation Oncology, University of California, San Francisco, CA, USA